Florian R Schroeck1,2,3,4, A Aziz Ould Ismail1, Grace N Perry5, David A Haggstrom6,7,8, Steven L Sanchez6, DeRon R Walker6, Jeanette Young9, Susan Zickmund5,9, Lisa Zubkoff10,11. 1. From the White River Junction VA Medical Center, White River Junction, VT. 2. Section of Urology, Dartmouth Hitchcock Medical Center, Lebanon, NH. 3. Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH. 4. The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, Hanover, NH. 5. Department of Medicine, University of Utah, Salt Lake City, UT. 6. VA HSR&D Center for Health Information and Communication, Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, IN. 7. Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, IN. 8. Regenstrief Institute, Indianapolis, IN. 9. VA Salt Lake City Health Care System, Salt Lake City, UT. 10. Birmingham/Atlanta VA Geriatric Research Education and Clinical Center (GRECC), Department of Veterans Affairs, Birmingham, AL. 11. Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Abstract
PURPOSE: For many patients with cancer, the frequency of surveillance after primary treatment depends on the risk for cancer recurrence or progression. Lack of risk-aligned surveillance means too many unnecessary surveillance procedures for low-risk patients and not enough for high-risk patients. Using bladder cancer as an example, we examined whether practice determinants differ between Department of Veterans Affairs sites where risk-aligned surveillance was more (risk-aligned sites) or less common (need improvement sites). METHODS: We used our prior quantitative data to identify two risk-aligned sites and four need improvement sites. We performed semistructured interviews with 40 Veterans Affairs staff guided by the Tailored Implementation for Chronic Diseases framework that were deductively coded. We integrated quantitative data (risk-aligned site v need improvement site) and qualitative data from interviews, cross-tabulating salient determinants by site type. RESULTS: There were 14 participants from risk-aligned sites and 26 participants from need improvement sites. Irrespective of site type, we found a lack of knowledge on guideline recommendations. Additional salient determinants at need improvement sites were a lack of resources ("the next available without overbooking is probably seven to eight weeks out") and an absence of routines to incorporate risk-aligned surveillance ("I have my own guidelines that I've been using for 35 years"). CONCLUSION: Knowledge, resources, and lack of routines were salient barriers to risk-aligned bladder cancer surveillance. Implementation strategies addressing knowledge and resources can likely contribute to more risk-aligned surveillance. In addition, reminders for providers to incorporate risk into their surveillance plans may improve their routines.
PURPOSE: For many patients with cancer, the frequency of surveillance after primary treatment depends on the risk for cancer recurrence or progression. Lack of risk-aligned surveillance means too many unnecessary surveillance procedures for low-risk patients and not enough for high-risk patients. Using bladder cancer as an example, we examined whether practice determinants differ between Department of Veterans Affairs sites where risk-aligned surveillance was more (risk-aligned sites) or less common (need improvement sites). METHODS: We used our prior quantitative data to identify two risk-aligned sites and four need improvement sites. We performed semistructured interviews with 40 Veterans Affairs staff guided by the Tailored Implementation for Chronic Diseases framework that were deductively coded. We integrated quantitative data (risk-aligned site v need improvement site) and qualitative data from interviews, cross-tabulating salient determinants by site type. RESULTS: There were 14 participants from risk-aligned sites and 26 participants from need improvement sites. Irrespective of site type, we found a lack of knowledge on guideline recommendations. Additional salient determinants at need improvement sites were a lack of resources ("the next available without overbooking is probably seven to eight weeks out") and an absence of routines to incorporate risk-aligned surveillance ("I have my own guidelines that I've been using for 35 years"). CONCLUSION: Knowledge, resources, and lack of routines were salient barriers to risk-aligned bladder cancer surveillance. Implementation strategies addressing knowledge and resources can likely contribute to more risk-aligned surveillance. In addition, reminders for providers to incorporate risk into their surveillance plans may improve their routines.
Authors: Adam J Rose; Beth Ann Petrakis; Patricia Callahan; Scott Mambourg; Dimple Patel; Elaine M Hylek; Barbara G Bokhour Journal: Health Serv Res Date: 2012-02-02 Impact factor: 3.402
Authors: Michel Wensing; Andy Oxman; Richard Baker; Maciek Godycki-Cwirko; Signe Flottorp; Joachim Szecsenyi; Jeremy Grimshaw; Martin Eccles Journal: Implement Sci Date: 2011-09-07 Impact factor: 7.327
Authors: Talya Salz; Morris Weinberger; John Z Ayanian; Noel T Brewer; Craig C Earle; Jennifer Elston Lafata; Deborah A Fisher; Bryan J Weiner; Robert S Sandler Journal: BMC Health Serv Res Date: 2010-09-01 Impact factor: 2.655
Authors: Wassim Kassouf; Samer L Traboulsi; Bernd Schmitz-Dräger; Joan Palou; Johannes Alfred Witjes; Bas W G van Rhijn; Herbert Barton Grossman; Lambertus A Kiemeney; Peter J Goebell; Ashish M Kamat Journal: Urol Oncol Date: 2016-06-29 Impact factor: 3.498
Authors: Florian R Schroeck; Amanda St Ivany; William Lowrance; Danil V Makarov; Philip P Goodney; Lisa Zubkoff Journal: JCO Oncol Pract Date: 2020-03-02
Authors: Chiamaka L Okorie; Elise Gatsby; Florian R Schroeck; A Aziz Ould Ismail; Kristine E Lynch Journal: PLoS One Date: 2022-05-13 Impact factor: 3.752
Authors: Florian R Schroeck; A Aziz Ould Ismail; David A Haggstrom; Steven L Sanchez; DeRon R Walker; Lisa Zubkoff Journal: Implement Sci Date: 2022-09-01 Impact factor: 7.960